178 related articles for article (PubMed ID: 22127978)
41. Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production.
Gabhann JN; Higgs R; Brennan K; Thomas W; Damen JE; Ben Larbi N; Krystal G; Jefferies CA
J Immunol; 2010 Mar; 184(5):2314-20. PubMed ID: 20100929
[TBL] [Abstract][Full Text] [Related]
42. Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus.
Zhang Z; Shi L; Song L; Ephrem E; Petri M; Sullivan KE
Arthritis Rheumatol; 2015 Mar; 67(3):785-96. PubMed ID: 25418955
[TBL] [Abstract][Full Text] [Related]
43. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
44. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
45. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons.
Stone RC; Feng D; Deng J; Singh S; Yang L; Fitzgerald-Bocarsly P; Eloranta ML; Rönnblom L; Barnes BJ
Arthritis Rheum; 2012 Mar; 64(3):788-98. PubMed ID: 21968701
[TBL] [Abstract][Full Text] [Related]
46. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3.
Molle C; Nguyen M; Flamand V; Renneson J; Trottein F; De Wit D; Willems F; Goldman M; Goriely S
J Immunol; 2007 Jun; 178(12):7607-15. PubMed ID: 17548596
[TBL] [Abstract][Full Text] [Related]
47. Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients.
Huang X; Hua J; Shen N; Chen S
Mod Rheumatol; 2007; 17(3):220-3. PubMed ID: 17564777
[TBL] [Abstract][Full Text] [Related]
48. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway.
Shime H; Yabu M; Akazawa T; Kodama K; Matsumoto M; Seya T; Inoue N
J Immunol; 2008 Jun; 180(11):7175-83. PubMed ID: 18490716
[TBL] [Abstract][Full Text] [Related]
49. Aging-dependent upregulation of IL-23p19 gene expression in dendritic cells is associated with differential transcription factor binding and histone modifications.
El Mezayen R; El Gazzar M; Myer R; High KP
Aging Cell; 2009 Sep; 8(5):553-65. PubMed ID: 19624579
[TBL] [Abstract][Full Text] [Related]
50. Adenosine Modulates NR4A Orphan Nuclear Receptors To Attenuate Hyperinflammatory Responses in Monocytic Cells.
Crean D; Cummins EP; Bahar B; Mohan H; McMorrow JP; Murphy EP
J Immunol; 2015 Aug; 195(4):1436-48. PubMed ID: 26150530
[TBL] [Abstract][Full Text] [Related]
51. Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter.
Sheikh SZ; Kobayashi T; Matsuoka K; Onyiah JC; Plevy SE
J Biol Chem; 2011 Jan; 286(2):1174-80. PubMed ID: 21097874
[TBL] [Abstract][Full Text] [Related]
52. Interferon regulatory factor 3 plays a role in macrophage responses to interferon-γ.
Guinn ZP; Petro TM
Immunobiology; 2019 Jul; 224(4):565-574. PubMed ID: 31072630
[TBL] [Abstract][Full Text] [Related]
53. A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression.
Sato S; Lennard Richard M; Brandon D; Jones Buie JN; Oates JC; Gilkeson GS; Zhang XK
Arthritis Rheumatol; 2014 Dec; 66(12):3436-44. PubMed ID: 25155007
[TBL] [Abstract][Full Text] [Related]
54. Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.
Yuan W; DiMartino SJ; Redecha PB; Ivashkiv LB; Salmon JE
Arthritis Rheum; 2011 Jan; 63(1):212-8. PubMed ID: 20954190
[TBL] [Abstract][Full Text] [Related]
55. Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway.
Wang J; Xie L; Wang S; Lin J; Liang J; Xu J
Cell Death Dis; 2018 Oct; 9(11):1080. PubMed ID: 30348950
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients.
Murayama G; Chiba A; Kuga T; Makiyama A; Yamaji K; Tamura N; Miyake S
Rheumatology (Oxford); 2020 Oct; 59(10):2992-3002. PubMed ID: 32160289
[TBL] [Abstract][Full Text] [Related]
57. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.
Sieber J; Daridon C; Fleischer SJ; Fleischer V; Hiepe F; Alexander T; Heine G; Burmester GR; Fillatreau S; Dörner T
Arthritis Res Ther; 2014 Nov; 16(6):477. PubMed ID: 25385499
[TBL] [Abstract][Full Text] [Related]
58. Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3.
Liu Y; Mo CF; Luo XY; Li H; Guo HJ; Sun H; Hu S; Li LM; Wang YT; Yang SX; Chang S; Zou Q
J Innate Immun; 2020; 12(4):304-320. PubMed ID: 31865314
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity.
Suzuki H; Takemura H; Kashiwagi H
Arthritis Rheum; 1995 Aug; 38(8):1055-9. PubMed ID: 7639800
[TBL] [Abstract][Full Text] [Related]
60. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice.
Mühlbauer M; Chilton PM; Mitchell TC; Jobin C
J Biol Chem; 2008 May; 283(21):14182-9. PubMed ID: 18375954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
